OTLK logo
OTLK

Outlook Therapeutics Inc

Biotechnology

Outlook Therapeutics Inc (OTLK) Insider Trading

7 transactions reported on SEC Form 4 — executive and director buys and sells.

Buys
4
Sells
0
Net value
$2.5M
InsiderTitleTypeSharesValueDate
KENYON LAWRENCE AChief Financial OfficerBuy101,010—Aug 14, 2026
Sukhtian Ghiath M.Buy2,525,252$2.5MAug 12, 2026
Jahr Robert CharlesChief Executive OfficerBuy151,515—Aug 14, 2026
Jahr Robert CharlesChief Executive OfficerGrant100,000—Jul 21, 2026
KENYON LAWRENCE AChief Financial OfficerGrant210,078—Jul 21, 2026
Sukhtian Ghiath M.Buy8,539,709$0May 28, 2026
Sukhtian Ghiath M.H3,458,571—May 28, 2026